Company news

Bora Pharmaceuticals Co Ltd news in 2026

Bora Pharmaceuticals Co Ltd's news releases, calls and decks from 2026, newest first.

View company

Upsher-Smith launches fluvoxamine maleate Extended-Release capsules

September 30, 2026

Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development

July 13, 2026

Announcement on the Company's resolution on cash dividend date（correction and additional Information on Items 12 to 16）

July 6, 2026

Bora Pharmaceuticals Completes Acquisition of MacroGenics' Rockville Manufacturing Operations

July 2, 2026

Upsher-Smith expands KYMBEE™ (deflazacort) family of products with launch of Oral Suspension for the treatment of Duchenne muscular dystrophy

June 23, 2026

Bora Pharmaceuticals Announce on behalf of material subsidiary Bora Pharmaceutical Holdings, LLC. to acquire the product licenses and rights

June 18, 2026

Upsher-Smith launches new online resources to Support The Duchenne community

April 14, 2026

Upsher-Smith launches generic version of Ciprodex® (Ciprofloxacin 0.3% and Dexamethasone 0.1%) sterile Otic Suspension

April 6, 2026

Bora Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12th

March 3, 2026

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract

February 23, 2026

Decks in 2026